Advertisement

Management of Tracheobronchial Diseases in Critically Ill Cancer Patients

  • Donald R. Lazarus
  • George A. EapenEmail author
Reference work entry

Abstract

Tracheobronchial diseases are uncommon in critically ill oncologic patients but are responsible for significant morbidity and risk of mortality in this population. The most significant tracheobronchial diseases of relevance in oncologic critical care are hemoptysis and central airway obstruction. In the inpatient setting, hemoptysis is most often related to lung cancer or bronchiectasis. After initial stabilization of the airway, localizing the source of bleeding and resuscitation are paramount. Then intervention to control bleeding and prevent recurrence with bronchial artery embolization or therapeutic bronchoscopy is indicated, with surgery most appropriately used for those patients refractory to less invasive management. Central airway obstruction refers to narrowing of the trachea or mainstem bronchi and can result from the direct effect of malignant tumors or complications of treatment. Patients often have severe obstruction before becoming symptomatic. If surgical resection is not possible, therapeutic bronchoscopy is the mainstay of treatment. Effective techniques used in central airway obstruction include laser photoresection, electrocautery, argon plasma coagulation, microdebrider bronchoscopy, bronchoplasty, and stenting. Complex stenoses often require multimodality therapy. A multidisciplinary approach is recommended.

Keywords

Hemoptysis Airway obstruction Tracheobronchial 

References

  1. 1.
    Amirana M, Frater R, Tirschwell P, Janis M, Bloomberg A, State D. An aggressive surgical approach to significant hemoptysis in patients with pulmonary tuberculosis. Am Rev Respir Dis. 1968; 97:187–92.  https://doi.org/10.1164/arrd.1968.97.2.187.CrossRefPubMedGoogle Scholar
  2. 2.
    Beamis JF Jr. Interventional pulmonology techniques for treating malignant large airway obstruction: an update. Curr Opin Pulm Med. 2005;11:292–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Bidwell JL, Pachner RW. Hemoptysis: diagnosis and management. Am Fam Physician. 2005;72:1253–60.PubMedGoogle Scholar
  4. 4.
    Bolliger CT, Sutedja TG, Strausz J, Freitag L. Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents. Eur Respir J. 2006;27:1258–71.  https://doi.org/10.1183/09031936.06.00013906.CrossRefPubMedGoogle Scholar
  5. 5.
    Boxem T, Muller M, Venmans B, Postmus P, Sutedja T. Nd-YAG laser vs bronchoscopic electrocautery for palliation of symptomatic airway obstruction: a cost-effectiveness study. Chest. 1999;116:1108–12.PubMedCrossRefGoogle Scholar
  6. 6.
    Breuer HW, Charchut S, Worth H, Trampisch HJ, Glanzer K. Endobronchial versus intravenous application of the vasopressin derivative glypressin during diagnostic bronchoscopy. Eur Respir J. 1989;2:225–8.PubMedGoogle Scholar
  7. 7.
    Brinson GM, Noone PG, Mauro MA, Knowles MR, Yankaskas JR, Sandhu JS, Jaques PF. Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis. Am J Respir Crit Care Med. 1998;157:1951–8.  https://doi.org/10.1164/ajrccm.157.6.9708067.CrossRefPubMedGoogle Scholar
  8. 8.
    Casal RF. Update in airway stents. Curr Opin Pulm Med. 2010;16:321–8.  https://doi.org/10.1097/MCP.0b013e32833a260.CrossRefPubMedGoogle Scholar
  9. 9.
    Casal RF, et al. Safety and effectiveness of microdebrider bronchoscopy for the management of central airway obstruction. Respirology. 2013;18:1011–5.  https://doi.org/10.1111/resp.12087.CrossRefPubMedGoogle Scholar
  10. 10.
    Cavaliere S, Foccoli P, Farina PL. Nd:YAG laser bronchoscopy. A five-year experience with 1,396 applications in 1,000 patients. Chest. 1988;94:15–21.PubMedCrossRefGoogle Scholar
  11. 11.
    Cavaliere S, Foccoli P, Toninelli C, Feijo S. Nd:YAG laser therapy in lung cancer: an 11-year experience with 2253 applications in 1585 patients. J Bronchol. 1994;1:105–11.CrossRefGoogle Scholar
  12. 12.
    Cavaliere S, Venuta F, Foccoli P, Toninelli C, La Face B. Endoscopic treatment of malignant airway obstructions in 2,008 patients. Chest. 1996;110: 1536–42.PubMedCrossRefGoogle Scholar
  13. 13.
    Charokopos N, Foroulis CN, Rouska E, Sileli MN, Papadopoulos N, Papakonstantinou C. The management of post-intubation tracheal stenoses with self-expandable stents: early and long-term results in 11 cases. Eur J Cardiothorac Surg. 2011;40:919–24.  https://doi.org/10.1016/j.ejcts.2010.12.042.CrossRefPubMedGoogle Scholar
  14. 14.
    Chhajed PN, et al. Therapeutic bronchoscopy for malignant airway stenoses: choice of modality and survival. J Cancer Res Ther. 2010;6:204–9.  https://doi.org/10.4103/0973-1482.65250.CrossRefPubMedGoogle Scholar
  15. 15.
    Conlan AA, Hurwitz SS. Management of massive haemoptysis with the rigid bronchoscope and cold saline lavage. Thorax. 1980;35:901–4.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Corey R, Hla KM. Major and massive hemoptysis: reassessment of conservative management. Am J Med Sci. 1987;294:301–9.PubMedCrossRefGoogle Scholar
  17. 17.
    Coulter TD, Mehta AC. The heat is on: impact of endobronchial electrosurgery on the need for Nd-YAG laser photoresection. Chest. 2000;118: 516–21.PubMedCrossRefGoogle Scholar
  18. 18.
    Crocco JA, Rooney JJ, Fankushen DS, DiBenedetto RJ, Lyons HA. Massive hemoptysis. Arch Intern Med. 1968;121:495–8.PubMedCrossRefGoogle Scholar
  19. 19.
    de Gracia J, de la Rosa D, Catalan E, Alvarez A, Bravo C, Morell F. Use of endoscopic fibrinogen-thrombin in the treatment of severe hemoptysis. Respir Med. 2003;97:790–5.PubMedCrossRefGoogle Scholar
  20. 20.
    Ducic Y, Khalafi RS. Use of endoscopically placed expandable nitinol tracheal stents in the treatment of tracheal stenosis. Laryngoscope. 1999;109:1130–3.PubMedCrossRefGoogle Scholar
  21. 21.
    Dumon JF. A dedicated tracheobronchial stent. Chest. 1990;97:328–32.PubMedCrossRefGoogle Scholar
  22. 22.
    Dumon JF, Reboud E, Garbe L, Aucomte F, Meric B. Treatment of tracheobronchial lesions by laser photoresection. Chest. 1982;81:278–84.PubMedCrossRefGoogle Scholar
  23. 23.
    Dupree HJ, Lewejohann JC, Gleiss J, Muhl E, Bruch HP. Fiberoptic bronchoscopy of intubated patients with life-threatening hemoptysis. World J Surg. 2001;25:104–7.PubMedCrossRefGoogle Scholar
  24. 24.
    Dutau H, Toutblanc B, Lamb C, Seijo L. Use of the Dumon Y-stent in the management of malignant disease involving the carina: a retrospective review of 86 patients. Chest. 2004;126:951–8.  https://doi.org/10.1378/chest.126.3.951.CrossRefPubMedGoogle Scholar
  25. 25.
    Earwood JS, Thompson TD. Hemoptysis: evaluation and management. Am Fam Physician. 2015;91:243–9.PubMedGoogle Scholar
  26. 26.
    Edmondstone WM, Nanson EM, Woodcock AA, Millard FJ, Hetzel MR. Life threatening haemoptysis controlled by laser photocoagulation. Thorax. 1983; 38:788–9.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Ernst A, Feller-Kopman D, Becker HD, Mehta AC. Central airway obstruction. Am J Respir Crit Care Med. 2004;169:1278–97.  https://doi.org/10.1164/rccm.200210-1181SO.CrossRefPubMedGoogle Scholar
  28. 28.
    Fartoukh M, et al. Early prediction of in-hospital mortality of patients with hemoptysis: an approach to defining severe hemoptysis. Respiration. 2012;83:106–14.  https://doi.org/10.1159/000331501.CrossRefPubMedGoogle Scholar
  29. 29.
    Garzon AA, Gourin A. Surgical management of massive hemoptysis. A ten-year experience. Ann Surg. 1978;187:267–71.PubMedPubMedCentralCrossRefGoogle Scholar
  30. 30.
    Geffin B, Grillo HC, Cooper JD, Pontoppidan H. Stenosis following tracheostomy for respiratory care. JAMA. 1971;216:1984–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Gong H Jr, Salvatierra C. Clinical efficacy of early and delayed fiberoptic bronchoscopy in patients with hemoptysis. Am Rev Respir Dis. 1981;124:221–5.  https://doi.org/10.1164/arrd.1981.124.3.221.CrossRefPubMedGoogle Scholar
  32. 32.
    Gourin A, Garzon AA. Operative treatment of massive hemoptysis. Ann Thorac Surg. 1974;18:52–60.PubMedCrossRefGoogle Scholar
  33. 33.
    Grillo HC. Reconstruction of the trachea. Experience in 100 consecutive cases. Thorax. 1973;28:667–79.PubMedPubMedCentralCrossRefGoogle Scholar
  34. 34.
    Han CC, Prasetyo D, Wright GM. Endobronchial palliation using Nd:YAG laser is associated with improved survival when combined with multimodal adjuvant treatments. J Thorac Oncol. 2007;2:59–64.  https://doi.org/10.1097/JTO.0b013e31802bff2d.CrossRefPubMedGoogle Scholar
  35. 35.
    Haponik EF, Britt EJ, Smith PL, Bleecker ER. Computed chest tomography in the evaluation of hemoptysis. Impact on diagnosis and treatment. Chest. 1987;91:80–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Herth F, Ernst A, Becker HD. Long-term outcome and lung cancer incidence in patients with hemoptysis of unknown origin. Chest. 2001;120:1592–4.PubMedCrossRefGoogle Scholar
  37. 37.
    Hetzel MR, Smith SG. Endoscopic palliation of tracheobronchial malignancies. Thorax. 1991;46:325–33.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Hetzel M, Hetzel J, Schumann C, Marx N, Babiak A. Cryorecanalization: a new approach for the immediate management of acute airway obstruction. J Thorac Cardiovasc Surg. 2004;127:1427–31.  https://doi.org/10.1016/j.jtcvs.2003.12.032.CrossRefPubMedGoogle Scholar
  39. 39.
    Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest. 1997;112:440–4.PubMedCrossRefGoogle Scholar
  40. 40.
    Hollingsworth HM. Wheezing and stridor. Clin Chest Med. 1987;8:231–40.PubMedGoogle Scholar
  41. 41.
    Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. AJR Am J Roentgenol. 2001;177:861–7.  https://doi.org/10.2214/ajr.177.4.1770861.CrossRefPubMedGoogle Scholar
  42. 42.
    Ibrahim WH. Massive haemoptysis: the definition should be revised. Eur Respir J. 2008;32:1131–2.  https://doi.org/10.1183/09031936.00080108.CrossRefPubMedGoogle Scholar
  43. 43.
    Ittrich H, Bockhorn M, Klose H, Simon M. The diagnosis and treatment of hemoptysis. Dtsch Arztebl Int. 2017;114:371–81.  https://doi.org/10.3238/arztebl.2017.0371.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Jones R, Charlton J, Latinovic R, Gulliford MC. Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study. BMJ. 2009;339:b3094.  https://doi.org/10.1136/bmj.b3094.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Keller CA, Hinerman R, Singh A, Alvarez F. The use of endoscopic argon plasma coagulation in airway complications after solid organ transplantation. Chest. 2001;119:1968–75.PubMedCrossRefGoogle Scholar
  46. 46.
    Khalil A, Fartoukh M, Tassart M, Parrot A, Marsault C, Carette MF. Role of MDCT in identification of the bleeding site and the vessels causing hemoptysis. AJR Am J Roentgenol. 2007;188:W117–25.  https://doi.org/10.2214/AJR.05.1578.CrossRefPubMedGoogle Scholar
  47. 47.
    Khalil A, Soussan M, Mangiapan G, Fartoukh M, Parrot A, Carette MF. Utility of high-resolution chest CT scan in the emergency management of haemoptysis in the intensive care unit: severity, localization and aetiology. Br J Radiol. 2007;80:21–5.  https://doi.org/10.1259/bjr/59233312.CrossRefPubMedGoogle Scholar
  48. 48.
    Knott-Craig CJ, Oostuizen JG, Rossouw G, Joubert JR, Barnard PM. Management and prognosis of massive hemoptysis. Recent experience with 120 patients. J Thorac Cardiovasc Surg. 1993;105:394–7.PubMedGoogle Scholar
  49. 49.
    Kvale PA, Eichenhorn MS, Radke JR, Miks V. YAG laser photoresection of lesions obstructing the central airways. Chest. 1985;87:283–8.PubMedCrossRefGoogle Scholar
  50. 50.
    Larici AR, et al. Diagnosis and management of hemoptysis. Diagn Interv Radiol. 2014;20:299–309.  https://doi.org/10.5152/dir.2014.13426.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Lordan JL, Gascoigne A, Corris PA. The pulmonary physician in critical care * Illustrative case 7: assessment and management of massive haemoptysis. Thorax. 2003;58:814–9.PubMedPubMedCentralCrossRefGoogle Scholar
  52. 52.
    Lunn W, Garland R, Ashiku S, Thurer RL, Feller-Kopman D, Ernst A. Microdebrider bronchoscopy: a new tool for the interventional bronchoscopist. Ann Thorac Surg. 2005;80:1485–8.  https://doi.org/10.1016/j.athoracsur.2004.12.023.CrossRefPubMedGoogle Scholar
  53. 53.
    Mal H, Rullon I, Mellot F, Brugiere O, Sleiman C, Menu Y, Fournier M. Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest. 1999;115:996–1001.PubMedCrossRefGoogle Scholar
  54. 54.
    Mathur PN, Wolf KM, Busk MF, Briete WM, Datzman M. Fiberoptic bronchoscopic cryotherapy in the management of tracheobronchial obstruction. Chest. 1996;110:718–23.PubMedCrossRefGoogle Scholar
  55. 55.
    McGuinness G, Beacher JR, Harkin TJ, Garay SM, Rom WN, Naidich DP. Hemoptysis: prospective high-resolution CT/bronchoscopic correlation. Chest. 1994;105:1155–62.PubMedCrossRefGoogle Scholar
  56. 56.
    Mehta AS, et al. Bronchial artery embolization for malignant hemoptysis: a single institutional experience. J Thorac Dis. 2015;7:1406–13.  https://doi.org/10.3978/j.issn.2072-1439.2015.07.39.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Miller RD, Hyatt RE. Evaluation of obstructing lesions of the trachea and larynx by flow-volume loops. Am Rev Respir Dis. 1973;108:475–81.  https://doi.org/10.1164/arrd.1973.108.3.475.CrossRefPubMedGoogle Scholar
  58. 58.
    Morice RC, Ece T, Ece F, Keus L. Endobronchial argon plasma coagulation for treatment of hemoptysis and neoplastic airway obstruction. Chest. 2001;119:781–7.PubMedCrossRefGoogle Scholar
  59. 59.
    Naidich DP, Funt S, Ettenger NA, Arranda C. Hemoptysis: CT-bronchoscopic correlations in 58 cases. Radiology. 1990;177:357–62.  https://doi.org/10.1148/radiology.177.2.2217769.CrossRefPubMedGoogle Scholar
  60. 60.
    Ong TH, Eng P. Massive hemoptysis requiring intensive care. Intensive Care Med. 2003;29:317–20.  https://doi.org/10.1007/s00134-002-1553-6.CrossRefPubMedGoogle Scholar
  61. 61.
    Ost DE, et al. Respiratory infections increase the risk of granulation tissue formation following airway stenting in patients with malignant airway obstruction. Chest. 2012;141:1473–81.  https://doi.org/10.1378/chest.11-2005.CrossRefPubMedGoogle Scholar
  62. 62.
    Pearson FG, Todd TR, Cooper JD. Experience with primary neoplasms of the trachea and carina. J Thorac Cardiovasc Surg. 1984;88:511–8.PubMedGoogle Scholar
  63. 63.
    Perin B, et al. Patient-related independent clinical risk factors for early complications following Nd: YAG laser resection of lung cancer. Ann Thorac Med. 2012;7:233–7.  https://doi.org/10.4103/1817-1737.102184.CrossRefPubMedPubMedCentralGoogle Scholar
  64. 64.
    Poe RH, et al. Utility of fiberoptic bronchoscopy in patients with hemoptysis and a nonlocalizing chest roentgenogram. Chest. 1988;93:70–5.PubMedCrossRefGoogle Scholar
  65. 65.
    Reddy C, Majid A, Michaud G, Feller-Kopman D, Eberhardt R, Herth F, Ernst A. Gas embolism following bronchoscopic argon plasma coagulation: a case series. Chest. 2008;134:1066–9.  https://doi.org/10.1378/chest.08-0474.CrossRefPubMedGoogle Scholar
  66. 66.
    Reichle G, Freitag L, Kullmann HJ, Prenzel R, Macha HN, Farin G. Argon plasma coagulation in bronchology: a new method – alternative or complementary? Pneumologie. 2000;54:508–16.  https://doi.org/10.1055/s-2000-8254.CrossRefPubMedGoogle Scholar
  67. 67.
    Remy J, et al. Treatment, by embolization, of severe or repeated hemoptysis associated with systemic hypervascularization. Nouv Presse Med. 1973;2:2060.PubMedGoogle Scholar
  68. 68.
    Remy J, Lemaitre L, Lafitte JJ, Vilain MO, Saint Michel J, Steenhouwer F. Massive hemoptysis of pulmonary arterial origin: diagnosis and treatment. AJR Am J Roentgenol. 1984;143:963–9.  https://doi.org/10.2214/ajr.143.5.963.CrossRefPubMedGoogle Scholar
  69. 69.
    Revel MP, Fournier LS, Hennebicque AS, Cuenod CA, Meyer G, Reynaud P, Frija G. Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? AJR Am J Roentgenol. 2002;179:1217–24.  https://doi.org/10.2214/ajr.179.5.1791217.CrossRefPubMedGoogle Scholar
  70. 70.
    Ross DJ, Mohsenifar Z, Koerner SK. Survival characteristics after neodymium: YAG laser photoresection in advanced stage lung cancer. Chest. 1990;98:581–5.PubMedCrossRefGoogle Scholar
  71. 71.
    Sakr L, Dutau H. Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management. Respiration. 2010;80:38–58.  https://doi.org/10.1159/000274492.CrossRefPubMedGoogle Scholar
  72. 72.
    Saumench J, Escarrabill J, Padro L, Montana J, Clariana A, Canto A. Value of fiberoptic bronchoscopy and angiography for diagnosis of the bleeding site in hemoptysis. Ann Thorac Surg. 1989;48:272–4.PubMedCrossRefGoogle Scholar
  73. 73.
    Savale L, et al. Cryptogenic hemoptysis: from a benign to a life-threatening pathologic vascular condition. Am J Respir Crit Care Med. 2007;175:1181–5.  https://doi.org/10.1164/rccm.200609-1362OC.CrossRefPubMedGoogle Scholar
  74. 74.
    Seijo LM, Ancochea J. In search of the ideal tracheobronchial stent: metal or silicone? Arch Bronconeumol. 2004;40:293–4.PubMedCrossRefGoogle Scholar
  75. 75.
    Set PA, Flower CD, Smith IE, Chan AP, Twentyman OP, Shneerson JM. Hemoptysis: comparative study of the role of CT and fiberoptic bronchoscopy. Radiology. 1993;189:677–80.  https://doi.org/10.1148/radiology.189.3.8234690.CrossRefPubMedGoogle Scholar
  76. 76.
    Sheski FD, Mathur PN. Endobronchial electrosurgery: argon plasma coagulation and electrocautery. Semin Respir Crit Care Med. 2004;25:367–74.  https://doi.org/10.1055/s-2004-832709.CrossRefPubMedGoogle Scholar
  77. 77.
    Shigemura N, et al. Multidisciplinary management of life-threatening massive hemoptysis: a 10-year experience. Ann Thorac Surg. 2009;87:849–53.  https://doi.org/10.1016/j.athoracsur.2008.11.010.CrossRefPubMedGoogle Scholar
  78. 78.
    Simoni P, Peters GE, Magnuson JS, Carroll WR. Use of the endoscopic microdebrider in the management of airway obstruction from laryngotracheal carcinoma. Ann Otol Rhinol Laryngol. 2003;112:11–3.  https://doi.org/10.1177/000348940311200103.CrossRefPubMedGoogle Scholar
  79. 79.
    Soares Pires F, Teixeira N, Coelho F, Damas C. Hemoptysis – etiology, evaluation and treatment in a university hospital. Rev Port Pneumol. 2011;17:7–14.PubMedCrossRefGoogle Scholar
  80. 80.
    Stoller JK. Spirometry: a key diagnostic test in pulmonary medicine. Cleve Clin J Med. 1992;59:75–8.PubMedCrossRefGoogle Scholar
  81. 81.
    Sutedja G, van Kralingen K, Schramel FM, Postmus PE. Fibreoptic bronchoscopic electrosurgery under local anaesthesia for rapid palliation in patients with central airway malignancies: a preliminary report. Thorax. 1994;49:1243–6.PubMedPubMedCentralCrossRefGoogle Scholar
  82. 82.
    Sutedja T, Van Boxem TJ, Schramel FM, Van Felius C, Postmus P. Endobronchial electrocautery is an excellent alternative to Nd:YAG laser to treat airway tumors. J Bronchol. 1997;4:101–5.CrossRefGoogle Scholar
  83. 83.
    Swanson KL, Johnson CM, Prakash UB, McKusick MA, Andrews JC, Stanson AW. Bronchial artery embolization: experience with 54 patients. Chest. 2002;121:789–95.PubMedCrossRefGoogle Scholar
  84. 84.
    Tanaka N, et al. Superselective bronchial artery embolization for hemoptysis with a coaxial microcatheter system. J Vasc Interv Radiol. 1997;8:65–70.PubMedCrossRefGoogle Scholar
  85. 85.
    Tsoumakidou M, Chrysofakis G, Tsiligianni I, Maltezakis G, Siafakas NM, Tzanakis N. A prospective analysis of 184 hemoptysis cases: diagnostic impact of chest x-ray, computed tomography, bronchoscopy. Respiration. 2006;73:808–14.  https://doi.org/10.1159/000091189.CrossRefPubMedGoogle Scholar
  86. 86.
    Tsukamoto T, Sasaki H, Nakamura H. Treatment of hemoptysis patients by thrombin and fibrinogen-thrombin infusion therapy using a fiberoptic bronchoscope. Chest. 1989;96:473–6.PubMedCrossRefGoogle Scholar
  87. 87.
    Tuller C, Tuller D, Tamm M, Brutsche MH. Hemodynamic effects of endobronchial application of ornipressin versus terlipressin. Respiration. 2004;71:397–401.  https://doi.org/10.1159/000079646.CrossRefPubMedGoogle Scholar
  88. 88.
    Valipour A, Kreuzer A, Koller H, Koessler W, Burghuber OC. Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis. Chest. 2005;127:2113–8.  https://doi.org/10.1378/chest.127.6.2113.CrossRefPubMedGoogle Scholar
  89. 89.
    van Boxem TJ, Venmans BJ, Schramel FM, van Mourik JC, Golding RP, Postmus PE, Sutedja TG. Radiographically occult lung cancer treated with fibreoptic bronchoscopic electrocautery: a pilot study of a simple and inexpensive technique. Eur Respir J. 1998;11:169–72.PubMedCrossRefGoogle Scholar
  90. 90.
    Vergnon JM, Huber RM, Moghissi K. Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers. Eur Respir J. 2006;28:200–18.  https://doi.org/10.1183/09031936.06.00014006.CrossRefPubMedGoogle Scholar
  91. 91.
    Walsh DA, Maiwand MO, Nath AR, Lockwood P, Lloyd MH, Saab M. Bronchoscopic cryotherapy for advanced bronchial carcinoma. Thorax. 1990; 45:509–13.PubMedPubMedCentralCrossRefGoogle Scholar
  92. 92.
    Wong ML, Szkup P, Hopley MJ. Percutaneous embolotherapy for life-threatening hemoptysis. Chest. 2002;121:95–102.PubMedCrossRefGoogle Scholar
  93. 93.
    Yoon W, Kim JK, Kim YH, Chung TW, Kang HK. Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. Radiographics. 2002;22:1395–409.  https://doi.org/10.1148/rg.226015180.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Baylor College of MedicineHoustonUSA
  2. 2.Department of Pulmonary Medicine, Division of Internal MedicineThe University of Texas MD Anderson Cancer CenterHoustonUSA

Section editors and affiliations

  • Yenny Cardenas
    • 1
  1. 1.Critical Care DepartmentUniversidad del Rosario Hospital Universitario Fundacion Santa Fe deBogotaColombia

Personalised recommendations